Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

This podcast contains general information for educational purposes only. This is not professional

advice and should not be used in lieu of obtaining advice from a qualified health care provider.

And now on to the show. Welcome to Helix Talk, episode 100. I'm your co-host, Dr. Keen.

I'm Dr. Patel. And with us today, we have a very special

guest, Dean Mark Abel, Dean of College of Pharmacy at Rosam Franklin University of Medicine and Science.

Thank you for joining us, Dr. Abel. Thank you for having me. I'm excited to have this conversation

with you. So, Dr. Abel, we asked you to come on to the episode because today's episode is a very special episode for us.

It's episode 100 of Helix Talk, and we wanted to kick off the episode by first thanking the

audience. We've received lots of emails, iTunes reviews, comments, things like that that

that have really motivated us to continue this podcast through 100 episodes and more. So we really

appreciate the audience support.

And we thought that it would only be fitting to have the dean of our college come for the 100th

episode to really talk about the profession of pharmacy and pharmacy education.

So the title of today's episode, episode 100, is evolution or revolution, the future of pharmacy

and pharmacy education. May I just add that I'm very proud of Dr. King? is Evolution or Revolution, the Future of Pharmacy and Pharmacy Education.

May I just add that I'm very proud of Dr. Kane, Dr. Patel, and also Dr. Schumann,

who has been a part of this podcast for a long time, and I'm pleased that we're able to produce this.

Absolutely. Well, let's kick it off by talking about some numbers.

In terms of pharmacy education,

if you look over the past five years, so we're looking at 2013 versus 2018, the most recent data,

...